GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials.
2023-10-20GenomeFrontier’s non-viral Quantum pBac was featured in an Genetic Engineering and Biotechnology News article on Streamlining CAR/TCR-T Therapy Manufacturing. (April 23, 2024)
2024-04-30
